Scholar Rock, INC.
Biopharmaceutical therapies targeting growth factors in serious diseases
Visit website ContactClaim & upgrade this listingContact details are protected Something wrong? Suggest a correction
Scholar Rock develops and delivers biopharmaceutical medicines for patients with serious diseases, including its listed medicine ISEMBYLD. Its research targets growth factors before activation, with a pipeline spanning neuromuscular and cardiometabolic disorders, cancer, fibrosis, and anemia.
At a Glance
Scholar Rock, INC. is an American manufacturer based in Cambridge, MA.
- Where
- Cambridge, MA
